Paper39198634
Attenuated effector T cells are linked to control of chronic HBV infection.
Heim K and 15 others. Nat Immunol, 2024. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Attenuated effector T cells are linked to control of chronic HBV infection. Papers, record 39198634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39198634
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B, Chronic | Major topic |
| Hepatitis B virus | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Humans | |
| Virus Replication | |
| Transforming Growth Factor beta | |
| Male | |
| Female | |
| Cell Differentiation | |
| Adult | |
| Middle Aged | |
| Signal Transduction |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TRR 179 project no. 272983813 | Deutsche Forschungsgemeinschaft (German Research Foundation) | PubMed | ||
| CRC 1160 project no. 256073931 | Deutsche Forschungsgemeinschaft (German Research Foundation) | PubMed | ||
| CRC 1479 project no. 441891347 | Deutsche Forschungsgemeinschaft (German Research Foundation) | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12477811 | CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. | J Virol | 2003 | https://conductscience.org/library/papers/12477811 | PubMed |
| 2 | 10770795 | The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. | J Exp Med | 2000 | https://conductscience.org/library/papers/10770795 | PubMed |
| 3 | 15140968 | Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. | J Virol | 2004 | https://conductscience.org/library/papers/15140968 | PubMed |
| 4 | 17287266 | Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. | J Virol | 2007 | https://conductscience.org/library/papers/17287266 | PubMed |
| 5 | 18695005 | Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. | J Exp Med | 2008 | https://conductscience.org/library/papers/18695005 | PubMed |
| 6 | 25225458 | Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. | J Exp Med | 2014 | https://conductscience.org/library/papers/25225458 | PubMed |
| 7 | 27452473 | Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host. | Cell Rep | 2016 | https://conductscience.org/library/papers/27452473 | PubMed |
| 8 | 28165481 | Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. | Nat Med | 2017 | https://conductscience.org/library/papers/28165481 | PubMed |
| 9 | 33097558 | TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection. | Gut | 2020 | https://conductscience.org/library/papers/33097558 | PubMed |
| 10 | 26205583 | Molecular and cellular insights into T cell exhaustion. | Nat Rev Immunol | 2015 | https://conductscience.org/library/papers/26205583 | PubMed |
| 11 | 30676822 | CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. | Annu Rev Immunol | 2019 | https://conductscience.org/library/papers/30676822 | PubMed |
| 12 | 20548953 | Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/20548953 | PubMed |
| 13 | 31207605 | TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. | Nature | 2019 | https://conductscience.org/library/papers/31207605 | PubMed |
| 14 | 18809920 | Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18809920 | PubMed |
| 15 | 27533016 | T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. | Immunity | 2016 | https://conductscience.org/library/papers/27533016 | PubMed |
| 16 | 30622109 | Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load. | Gut | 2019 | https://conductscience.org/library/papers/30622109 | PubMed |
| 17 | 30580250 | Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. | Gut | 2019 | https://conductscience.org/library/papers/30580250 | PubMed |
| 18 | 37541771 | Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells. | Gut | 2023 | https://conductscience.org/library/papers/37541771 | PubMed |
| 19 | 34702717 | Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection. | Gut | 2022 | https://conductscience.org/library/papers/34702717 | PubMed |
| 20 | 27084039 | Adaptive immunity in HBV infection. | J Hepatol | 2016 | https://conductscience.org/library/papers/27084039 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769860 | From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42769860 | PubMed |
| 42728401 | ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer. | Nat Immunol | 2026 | https://conductscience.org/library/papers/42728401 | PubMed |
| 42713265 | Immune correlates of outcomes after nucleos(t)ide analogue withdrawal in chronic hepatitis B: direct evidence, mechanistic context, and candidate biomarkers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42713265 | PubMed |
| 42638743 | The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B. | Front Immunol | 2026 | https://conductscience.org/library/papers/42638743 | PubMed |
| 42519330 | From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42519330 | PubMed |
| 42387268 | A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection. | Aliment Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42387268 | PubMed |
| 42380632 | New insights into progenitor exhausted T cell populations. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/42380632 | PubMed |
| 42350969 | Association between changes in HBsAb levels and hepatic adverse events after HBsAg clearance in non-cirrhotic chronic hepatitis B patients. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42350969 | PubMed |
| 42315521 | Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B. | Nat Commun | 2026 | https://conductscience.org/library/papers/42315521 | PubMed |
| 42310165 | Compensatory relationships determine the impact of TGF-β on the humoral immune response to hepatitis B surface antigen. | J Immunol | 2026 | https://conductscience.org/library/papers/42310165 | PubMed |
| 42179967 | An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinoma. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42179967 | PubMed |
| 42050590 | Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review. | Infect Agent Cancer | 2026 | https://conductscience.org/library/papers/42050590 | PubMed |
| 42033764 | Clonal amplification of peripheral CD4+ and CD8+ T cells is associated with clinical response to checkpoint blockade in chronic hepatitis B. | Immunohorizons | 2026 | https://conductscience.org/library/papers/42033764 | PubMed |
| 42009166 | Persistent loss of intrahepatic IFN-γ in HBV is linked to selective impairment of liver-resident CXCR6+NK cells despite long-term NUC therapy. | JHEP Rep | 2026 | https://conductscience.org/library/papers/42009166 | PubMed |
| 41912891 | T cell adaptation in chronic infections and tumors. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/41912891 | PubMed |
| 41899088 | Heterogeneity Analysis of HBeAg-Positive Chronic Hepatitis B Patients with Ultra-High Viral Load (HBV DNA ≥ 7.0 log10 IU/mL). | J Clin Med | 2026 | https://conductscience.org/library/papers/41899088 | PubMed |
| 41863669 | T-Cell Profiles in HBV Functional Cure and People Living With HIV: Known Knowns, Known Unknowns, and Unknown Unknowns. | Curr HIV/AIDS Rep | 2026 | https://conductscience.org/library/papers/41863669 | PubMed |
| 41851274 | Renaissance of antiviral CD8+ T cell immunity in vaccination and disease. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/41851274 | PubMed |
| 41704420 | Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41704420 | PubMed |
| 41601689 | Terminally exhausted CD8+ T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601689 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39198634
GET https://conductscience.org/api/papers/v1/39198634/references?page=2